Saturday, August 15, 2020

Daily Archives: June 21, 2004

Medtronic Announces FDA Approval of Smaller Implantable Drug Pump for Chronic Pain, Severe Spasticity

Published: June 21, 2004

New programmable pump features greater accuracy, larger reservoirs and longer refill intervals, making treatments more convenient and easier to manage

Medtronic, Inc. (NYSE:MDT), today announced that it has received approval from the U.S. Food and Drug Administration for its SynchroMed(R) II Programmable Pump for the treatment of chronic pain and the management of severe Spasticity – the tight, stiff muscles commonly associated with cerebral palsy, Multiple Sclerosis, stroke, brain injury and spinal cord injury.